Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CRISPR/Cas9 in allergic and immunologic diseases.

Literature DB >> 27687572

CRISPR/Cas9 in allergic and immunologic diseases.

Michael A Goodman^1,2, Donya Moradi Manesh², Punam Malik², Marc E Rothenberg¹.

Abstract

Entities: Chemical Disease Gene Mutation Species

Keywords: CRISPR/Cas9; allergic disease; gene editing; gene regulation; immunologic disease

Mesh：

Substances：
Cytidine Deaminase

Year: 2016 PMID： 27687572 PMCID： PMC5592636 DOI： 10.1080/1744666X.2017.1241711

Source DB: PubMed Journal: Expert Rev Clin Immunol ISSN： 1744-666X Impact factor: 4.473

× No keyword cloud information.

45 in total

Review 1. The alveolar macrophages in asthma: a double-edged sword.

Authors: J Balhara; A S Gounni
Journal: Mucosal Immunol Date: 2012-08-22 Impact factor: 7.313

2. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects.

Authors: Bin Shen; Wensheng Zhang; Jun Zhang; Jiankui Zhou; Jianying Wang; Li Chen; Lu Wang; Alex Hodgkins; Vivek Iyer; Xingxu Huang; William C Skarnes
Journal: Nat Methods Date: 2014-03-02 Impact factor: 28.547

Review 3. The clinical applications of genome editing in HIV.

Authors: Cathy X Wang; Paula M Cannon
Journal: Blood Date: 2016-04-06 Impact factor: 22.113

4. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.

Authors: Christopher E Nelson; Chady H Hakim; David G Ousterout; Pratiksha I Thakore; Eirik A Moreb; Ruth M Castellanos Rivera; Sarina Madhavan; Xiufang Pan; F Ann Ran; Winston X Yan; Aravind Asokan; Feng Zhang; Dongsheng Duan; Charles A Gersbach
Journal: Science Date: 2015-12-31 Impact factor: 47.728

5. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.

Authors: Prashant Mali; John Aach; P Benjamin Stranges; Kevin M Esvelt; Mark Moosburner; Sriram Kosuri; Luhan Yang; George M Church
Journal: Nat Biotechnol Date: 2013-08-01 Impact factor: 54.908

6. The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo.

Authors: Su-Ru Lin; Hung-Chih Yang; Yi-Ting Kuo; Chun-Jen Liu; Ta-Yu Yang; Ku-Chun Sung; You-Yu Lin; Hurng-Yi Wang; Chih-Chiang Wang; Yueh-Chi Shen; Fang-Yi Wu; Jia-Horng Kao; Ding-Shinn Chen; Pei-Jer Chen
Journal: Mol Ther Nucleic Acids Date: 2014-08-19 Impact factor: 10.183

7. In vivo genome editing using Staphylococcus aureus Cas9.

Authors: F Ann Ran; Le Cong; Winston X Yan; David A Scott; Jonathan S Gootenberg; Andrea J Kriz; Bernd Zetsche; Ophir Shalem; Xuebing Wu; Kira S Makarova; Eugene V Koonin; Phillip A Sharp; Feng Zhang
Journal: Nature Date: 2015-04-01 Impact factor: 49.962

8. Multiplexable, locus-specific targeting of long RNAs with CRISPR-Display.

Authors: David M Shechner; Ezgi Hacisuleyman; Scott T Younger; John L Rinn
Journal: Nat Methods Date: 2015-06-01 Impact factor: 28.547

9. Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients.

Authors: David G Ousterout; Pablo Perez-Pinera; Pratiksha I Thakore; Ami M Kabadi; Matthew T Brown; Xiaoxia Qin; Olivier Fedrigo; Vincent Mouly; Jacques P Tremblay; Charles A Gersbach
Journal: Mol Ther Date: 2013-06-04 Impact factor: 11.454